×
About 1,895 results

ALLMedicine™ Zollinger-Ellison Syndrome Center

Research & Reviews  132 results

Sporadic and MEN1-related gastrinoma and Zollinger-Ellison syndrome: differences in cli...
https://doi.org/10.1007/s40618-022-01961-w
Journal of Endocrinological Investigation; Massironi S, Rossi RE et. al.

Nov 28th, 2022 - Gastrinoma with Zollinger-Ellison syndrome (ZES) may occur sporadically (Sp) or as part of the inherited syndrome of multiple endocrine neoplasia 1 (MEN-1). Data comparing Sp and MEN-1/ZES are scanty. We aimed to identify and compare their clinica...

The Zollinger-Ellison Syndrome.
https://doi.org/10.1056/NEJMicm2203797
The New England Journal of Medicine; Binet Q, Borbath I

Nov 3rd, 2022 - The Zollinger-Ellison Syndrome.|2022|Binet Q,Borbath I,|complications,diagnosis,

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001254

Oct 7th, 2022 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Sporadic, non-functional, gastrin-producing duodenal neuroendocrine tumors: A retrospec...
https://doi.org/10.1111/1751-2980.13129
Journal of Digestive Diseases; de Jorge Huerta L, Solares Fernández I et. al.

Sep 29th, 2022 - Non-functioning gastrin-producing neuroendocrine neoplasms (NEN) of the duodenum are rare gastrointestinal tumors without a clinical syndrome due to gastrin production. Their incidence has significantly increased as an incidental finding during en...

Natural History Study of Parathyroid Disorders
https://clinicaltrials.gov/ct2/show/NCT04969926

Sep 23rd, 2022 - Study Description: Patients with confirmed, suspected or at risk of developing parathyroid disorders will be provided standard of care testing for their condition. Data obtained during the testing will be used for research. Additionally, samples m...

see more →

Drugs  575 results see all →

Clinicaltrials.gov  15 results

Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
https://clinicaltrials.gov/ct2/show/NCT00001254

Oct 7th, 2022 - This protocol concerns the approach to the localization and management of the tumor in patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used to localize the tumor and the subsequent management of the tumor.

Natural History Study of Parathyroid Disorders
https://clinicaltrials.gov/ct2/show/NCT04969926

Sep 23rd, 2022 - Study Description: Patients with confirmed, suspected or at risk of developing parathyroid disorders will be provided standard of care testing for their condition. Data obtained during the testing will be used for research. Additionally, samples m...

YF476 and Type II Gastric Carcinoids
https://clinicaltrials.gov/ct2/show/NCT02454075

Jan 29th, 2021 - This study will evaluate whether treatment with YF476 is safe and effective in reducing the size of type II gastric carcinoid tumours, or limiting the abnormal growth of gastric ECL cells, in patients with Zollinger-Ellison syndrome.

Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)
https://clinicaltrials.gov/ct2/show/NCT03213639

Jan 7th, 2021 - The key aspects in the pathophysiology of pre-eclampsia are placental oxidative stress (and hypoxia), placental release of the anti-angiogenic factors Soluble Fms Like Tyrosine Kinase -1 and soluble endoglin and maternal endothelial dysfunction. A...

Pancreatic Exocrine Insufficiency and Pancreatic Enzyme Supplementation in Critically Ill Adult Patients
https://clinicaltrials.gov/ct2/show/NCT01753024

Sep 6th, 2018 - Critically ill patients who is able to receive early enteral nutrition and estimated to stay in ICU at least four days are considered to enroll into this study. Exclusion criteria are age under 18 or over 80 years, pregnancy or breastfeeding, know...

see more →

News  27 results

Recognizing the Symptoms of NETs
https://www.onclive.com/view/recognizing-the-symptoms-of-nets

Apr 2nd, 2021 - Transcript: Simron Singh, MD: So Jon, we talked a bit about the patients who present with functional NETs [neuroendocrine tumors] or symptoms. What are some of the hormones that cause the symptoms you see in patients with neuroendocrine cancer...

Unraveling Neuroendocrine Tumors: Clinician Reflects on 60 Years of Discovery
https://www.onclive.com/view/unraveling-neuroendocrine-tumors-clinician-reflects-on-60-years-of-discovery

Dec 20th, 2020 - Richard R.P. Warner, MD The Early Years: Piecing Together Evidence At age 89, I could probably earn the Guinness World Record for the oldest neuroendocrine cancer clinician in the United States, and perhaps even the world. I retired from clinica...

Operating With Scientific Rigor: How Brennan Changed Cancer Surgery
https://www.onclive.com/view/operating-with-scientific-rigor-how-brennan-changed-cancer-surgery

Dec 5th, 2020 - Sir Murray F. Brennan, MD Sir Murray F. Brennan, MD, thought he was joining an empirical science when he began medical school in 1960, but by the time he had completed his residency, he realized that surgery was actually a mishmash of tradition a...

Continue, Stop, or Taper the PPI?
https://www.medscape.com/viewarticle/920314_2

Oct 25th, 2019 - My Take: It's Time for a Change. Do You Agree? The patient may not like it, but it's worth at least trying to taper his PPI at this time, with a goal of stopping regular PPI dosing altogether. Like many others, this patient is using his PPI as chr...

Improper Proton Pump Inhibitor Prescriptions Criticized
https://www.medscape.com/viewarticle/913377

May 22nd, 2019 - SAN DIEGO — Prescriptions for proton pump inhibitors (PPIs) have skyrocketed over the past 2 decades, along with concerns about inappropriate use and adverse events. Prescriptions for PPIs went from 1.6% of ambulatory care visits in 1998 to 7.6% i...

see more →

Patient Education  9 results see all →